首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Esmo open

缩写:

ISSN:N/A

e-ISSN:2059-7029

IF/分区:8.3/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2013
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
M R Kobbeltvedt,I Lobmaier,M Spreafico et al. M R Kobbeltvedt et al.
Background: Different risk classification criteria are used to select patients with localized soft tissue sarcoma of the extremities and trunk wall for neoadjuvant/adjuvant chemotherapy. The two most frequently used risk ...
G Griguolo,M V Dieci,S Fineberg et al. G Griguolo et al.
Background: Despite the clinical impact of breast cancer (BC) brain metastases (BMs), their biological complexity remains poorly understood. We evaluated the genomic profile of BCBMs and compared it with paired primary BC...
K Amrane,B Cabarrou,G Justeau et al. K Amrane et al.
Background: Among the aggressive non-small-cell lung carcinoma subtypes, pulmonary sarcomatoid carcinoma (PSC) is a rare and poorly understood tumor. This study was undertaken to evaluate the efficacy [progression-free su...
H E Fuentes Bayne,R Suleiman,R A Eiring et al. H E Fuentes Bayne et al.
Background: Cancer of unknown primary (CUP) remains a diagnostic and therapeutic challenge with limited treatment guidance. Caudal type homeobox 2 (CDX2), a transcription factor indicative of intestinal differentiation, m...
A D King,Y M Tsang,H S Leung et al. A D King et al.
The assessment of extranodal extension by imaging (iENE) is important in the management of patients with metastatic nodes from head and neck cancer (HNC). Over many decades iENE has guided surgical and radiotherapy planning using both early...
C Prieto-de-la-Lastra,J A Carbonell-Asins,A Bueno et al. C Prieto-de-la-Lastra et al.
Background: Accurately estimating relapse risk in localized colon cancer (LCC) remains a challenge, as clinicopathological staging often fails to differentiate patients with a higher likelihood of recurrence. There is a n...
V Daprà,A Gandini,F Schietroma et al. V Daprà et al.
Background: T4 is one of the most important prognostic factors in localized colon cancer (CC), especially in stage II (pT4N0). However, the optimal adjuvant treatment in this subset of patients remains unclear. We present...
E A Martino,G Caridà,D Lofaro et al. E A Martino et al.
Background: The treatment landscape for relapsed/refractory multiple myeloma (RRMM) is rapidly evolving, particularly for patients exposed or refractory to lenalidomide. With the aim of evaluating the relative efficacy of...